» Articles » PMID: 35459446

Effect of Continuous Positive Airway Pressure Treatment on Ambulatory Blood Pressures in High-risk Sleep Apnea Patients: a Randomized Controlled Trial

Overview
Specialties Neurology
Psychiatry
Date 2022 Apr 23
PMID 35459446
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: The long-term effect of continuous positive airway pressure (CPAP) on 24-hour blood pressure (BP) in patients at high risk with obstructive sleep apnea (OSA) is uncertain. We aimed to determine the effect of CPAP treatment on ambulatory BP in individuals with moderate or severe OSA and cardiovascular disease or multiple cardiovascular disease risk factors without severe sleepiness.

Methods: In this randomized, controlled, parallel group study, 169 participants were randomly assigned to CPAP treatment or the control group. The primary outcome was the change in mean 24-hour systolic BP between groups from baseline to the average of 6- and 12-month measurements using mixed-effect linear regression models.

Results: The 24-hour systolic BP did not significantly differ by group, although there was a trend of decrease in the CPAP group (treatment effect -2.7 mm Hg [95% confidence interval -5.9 to 0.6]; = .105) compared with control. CPAP had the greatest effect on nighttime systolic BP (treatment effect -5.9 mm Hg [95% confidence interval -9.9 to -1.9]; = .004). Similar improvements in other nocturnal BP indices were observed.

Conclusions: In patients at high risk with moderate-severe OSA without severe sleepiness, CPAP resulted in modest BP improvements over 6 to 12 months of follow-up, with possibly larger effects for nocturnal BP. Use of office blood pressure may underestimate the effect of CPAP on BP profile in patients with OSA.

Clinical Trial Registration: Registry: ClinicalTrials.gov; Title: Sleep Apnea Intervention for Cardiovascular Disease Reduction; Identifier: NCT01261390; URL: https://clinicaltrials.gov/ct2/show/NCT01261390.

Citation: Zhao YY, Wang R, Gleason KJ, et al. Effect of continuous positive airway pressure treatment on ambulatory blood pressures in high-risk sleep apnea patients: a randomized controlled trial. . 2022;18(8):1899-1907.

Citing Articles

A Narrative Review of the Clinical Trials in Sleep-Related Breathing Disorders from 2022 to Present.

Pihtili A, Gunduz Gurkan C, Habesoglu M, Ozturk O, Ozsancak Ugurlu A, Tasbakan M Thorac Res Pract. 2023; 25(1):42 - 49.

PMID: 38015164 PMC: 11160422. DOI: 10.5152/ThoracResPract.2023.23104.


Effects of chlorthalidone plus amiloride compared with amlodipine on short-term blood pressure variability in individuals with hypertension and obstructive sleep apnea: a randomized controlled trial.

Lucca M, Jorge J, Cichelero F, Martinez D, Borges R, Hirakata V Blood Press Monit. 2023; 28(6):289-294.

PMID: 37466401 PMC: 10621641. DOI: 10.1097/MBP.0000000000000663.

References
1.
Marin J, Carrizo S, Vicente E, Agusti A . Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365(9464):1046-53. DOI: 10.1016/S0140-6736(05)71141-7. View

2.
Montesi S, Edwards B, Malhotra A, Bakker J . The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med. 2012; 8(5):587-96. PMC: 3459209. DOI: 10.5664/jcsm.2170. View

3.
Gottlieb D, Punjabi N, Mehra R, Patel S, Quan S, Babineau D . CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 2014; 370(24):2276-85. PMC: 4172401. DOI: 10.1056/NEJMoa1306766. View

4.
Reid M, Gleason K, Bakker J, Wang R, Mittleman M, Redline S . The role of sham continuous positive airway pressure as a placebo in controlled trials: Best Apnea Interventions for Research Trial. Sleep. 2019; 42(8). PMC: 7182666. DOI: 10.1093/sleep/zsz099. View

5.
Bakker J, Wang R, Weng J, Aloia M, Toth C, Morrical M . Motivational Enhancement for Increasing Adherence to CPAP: A Randomized Controlled Trial. Chest. 2016; 150(2):337-45. PMC: 4980541. DOI: 10.1016/j.chest.2016.03.019. View